Print:

In-licensing for Chinese Market

Areas of interests:

Products/Technologies

  • Marketed products
  • Technology platforms: delivery systems & formulation technologies
  • Late-stage development projects (phase II or beyond)
  • Proprietary early-stage compounds/formulations (ready for IND)

Dosage forms: Injectables or Tablets

Therapeutic Areas Drugs
Hepatitis 1.Nucleoside analogues
2.Others: liver protectants, anti-fibrotic drugs, etc.
Cardiovascular 1.Microcirculation
2.Antithrombotic drugs
3.Anti-hypertension drugs
Anti-tumor Small molecule drugs and targeted therapies as tumor angiogenesis inhibitors and tyrosine-kinase inhibitors
Anti-infection 1.Cephalosporins
2.Quinolones

 

      <b id="kezxjet" ><center id="kezxjet" ></center></b>

    1. <code id="kezxjet" ><font id="kezxjet" ></font></code>
      <noframes id="kezxjet" ></noframes><small id="kezxjet" ><input id="kezxjet" ></input></small>
      <label id="kezxjet" ></label><th id="kezxjet" ><output id="kezxjet" ></output></th>

      <object id="kezxjet" ><delect id="kezxjet" ></delect></object>